on January 25, 2013 |
Permalink
Topics: Service Lines, Clinical Research, Clinical Technology, Orthopedics
Ashley Ford
For many institutions, orthopedics has traditionally been a prosperous service line known for its simplicity. Because of low barriers to entry and relatively stable growth, orthopedics is a marquee business across hospital strategic planning. In 2012, however, the orthopedics community experienced a few important debates leading to developments that will impact the industry in 2013.
During the first half of 2012, continued clinical concern was expressed about the complications associated with the use of metal-on-metal hips, and the second half of 2012 brought debate around the implications of proposed (then rescinded) outpatient joint replacement reimbursement.
To ensure that our members have access to networking opportunities and the most current orthopedics research, my colleagues and I launched our inaugural Orthopedics & Spine Summit – a day-long summit bringing together providers, physicians and suppliers to discuss the latest programmatic and technological trends in orthopedics and spine.
To help you prepare for 2013, we’ve compiled the top four technological trends to watch for in clinical orthopedics innovation across the year.
Continue reading:
What to watch for in orthopedics in 2013
on January 24, 2013 |
Permalink
Topics: Service Lines, Clinical Research, Clinical Technology, Orthopedics
Sam Gold
The often scrutinized metal-on-metal (MoM) hip implants have suffered yet another setback this month. In a statement issued on January 17, the FDA released updated safety standards for MoM implant systems, now requiring evaluation of MoM implant systems via premarket approval applications (PMAs) rather than the historically used 510(k) premarket notification program.
This applies to traditional total hip replacement systems and resurfacing hip systems. This shift signals action for which the orthopedics community has been asking since the June FDA panel. The panel reviewed the clinical controversies of these devices—specifically, the potentially fatal side effects associated with these treatments.
Continue reading:
FDA increases safety measures for metal-on-metal hip implants
on October 29, 2012 |
Permalink
Topics: Service Lines, Neurosciences, Orthopedics, Spine, Performance Improvement, Quality, Outcomes
Collin Kent
The 2012 NASS meeting in Dallas has reached its conclusion. Clinicians and scientists met to share and discuss the latest research impacting spine care. Of interest to the spine community and the subject of one presentation at the "Best Papers" symposia was the cost and quality of spine surgery compared to comprehensive medical management.
Continue reading:
NASS 2012: Quality and cost-effectiveness of surgery for lumbar spinal stenosis
